Male hypogonadism: A review of the disease and its treatment

U.S. Pharmacist

Volumn 35, Issue 6, 2010, Pages

  Sexson, Emily ^a   Knezevich, Jon ^a  

^a CREIGHTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; GONADORELIN; LUTEINIZING HORMONE; PROSTATE SPECIFIC ANTIGEN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TESTOSTERONE CIPIONATE; TESTOSTERONE ENANTATE;

ACNE; BREAST CANCER; CLINICAL ASSESSMENT; CLINICAL FEATURE; DEPRESSION; DRUG CONTRAINDICATION; DRUG COST; DRUG IMPLANTATION; DRUG WITHDRAWAL; ERYTHROCYTOSIS; GASTROINTESTINAL HEMORRHAGE; GYNECOMASTIA; HEADACHE; HORMONAL THERAPY; HUMAN; HYPOGONADISM; KLINEFELTER SYNDROME; MALE; MALE TYPE ALOPECIA; MUCOSA INFLAMMATION; OILY SKIN; PATHOPHYSIOLOGY; PROSTATE CANCER; PROSTATE HYPERTROPHY; RASH; REVIEW; SKIN IRRITATION; SLEEP APNEA SYNDROME; TESTOSTERONE BLOOD LEVEL; TREATMENT PLANNING;

EID: 77953974376     PISSN: 01484818     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Review

References (12)

1. Snyder PJ, Matsumoto AM, Martin KA. Testos-terone treatment of male hypogonadism. UpToDate. www.uptodate.com. Updated September 30, 2009. Accessed January 3, 2010.
2. Beg S, Al-Khoury L, Cunningham GR. Testosterone replacement in men. Curr Opin Endocrinol Diabetes Obes. 2008;15:364-370.
3. Seftel AD. Male hypogonadism. Part I: Epidemiology of hypogonadism. Int J Impot Res. 2006;18:115-120.
4. Snyder PJ, Matsumoto AM, Martin KA. UpToDate. Causes of primary hypogonadism in males. www.uptodate.com. Updated September 30, 2009. Accessed January 3, 2010.
5. Snyder PJ, Matsumoto AM, Martin KA. Causes of secondary hypogonadism in males. UpToDate. www.uptodate.com. Updated September 30, 2009. Accessed January 3, 2010.
6. Snyder PJ, Matsumoto AM, Martin KA, et al. Clinical features and diagnosis of male hypogonadism. UpToDate. www.uptodate.com. Updated September 30, 2009. Accessed January 3, 2010.
7. Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2006;91:1995-2010.
8. Seftel A. Testosterone replacement therapy for male hypogonadism: part III. Pharmacologic and clinical profiles, monitoring, safety issues, and potential future agents. Int J Impot Res. 2007;19:2-24.
9. Layman LC. Hypogonadotropic hypogonadism. Endocrinol Metab Clin N Am. 2007;36:283-296.
10. Shabsigh R, Crawford ED, Nehra A, Slawin KM. Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review. Int J Impot Res. 2009;21:9-23.
11. Marks L, Mazer N, Mostaghel E, et al. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial. JAMA. 2006;296:2351-2361.
12. Testopel (testosterone pellets) package insert. Rye, NY: Bartor Pharmacal Co., Inc; April 1992.